Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fenofibrate for diabetic retinopathy.

× No keyword cloud information.

17 in total

1. Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.

Authors: Sumon Roy; Dongjoon Kim; Cristina Hernández; Rafael Simó; Sayon Roy
Journal: Exp Eye Res Date: 2015-08-18 Impact factor: 3.467

Review 2. Hyperlipidemia: a new therapeutic target for diabetic neuropathy.

Authors: Andrea M Vincent; Lucy M Hinder; Rodica Pop-Busui; Eva L Feldman
Journal: J Peripher Nerv Syst Date: 2009-12 Impact factor: 3.494

Review 3. Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.

Authors: C Hernández; A Simó-Servat; P Bogdanov; R Simó
Journal: J Endocrinol Invest Date: 2017-03-29 Impact factor: 4.256

4. Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.

Authors: M Villarroel; M Garcia-Ramírez; L Corraliza; C Hernández; R Simó
Journal: Diabetologia Date: 2011-03-03 Impact factor: 10.122

5. Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability.

Authors: Kyle Trudeau; Sumon Roy; Wen Guo; Cristina Hernández; Marta Villarroel; Rafael Simó; Sayon Roy
Journal: Invest Ophthalmol Vis Sci Date: 2011-08-11 Impact factor: 4.799

Review 6. Is fenofibrate a reasonable treatment for diabetic microvascular disease?

Authors: Rafael Simó; Olga Simó-Servat; Cristina Hernández
Journal: Curr Diab Rep Date: 2015-05 Impact factor: 4.810

Review 7. Diabetic macular edema: correlations with available diabetes therapies--evidence across a qualitative review of published literature from MEDLINE and EMBASE.

Authors: Domenico Merante; Francesca Menchini; Kenneth E Truitt; Francesco M Bandello
Journal: Drug Saf Date: 2010-08-01 Impact factor: 5.606

Review 8. Advances in the medical treatment of diabetic retinopathy.

Authors: Rafael Simó; Cristina Hernández
Journal: Diabetes Care Date: 2009-08 Impact factor: 17.152

Review 9. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.

Authors: Rafael Simó; Marta Villarroel; Lídia Corraliza; Cristina Hernández; Marta Garcia-Ramírez
Journal: J Biomed Biotechnol Date: 2010-02-17

10. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.

Authors: Ying Chen; Yang Hu; Mingkai Lin; Alicia J Jenkins; Anthony C Keech; Robert Mott; Timothy J Lyons; Jian-xing Ma
Journal: Diabetes Date: 2012-10-05 Impact factor: 9.461